Skip to main content
Select Language
English
Afrikaans
Albanian
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chinese (Simplified)
Chinese (Traditional)
Croatian
Czech
Danish
Dutch
Esperanto
Estonian
Filipino
Finnish
French
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Khmer
Korean
Lao
Latin
Latvian
Lithuanian
Macedonian
Malay
Maltese
Maori
Marathi
Mongolian
Nepali
Norwegian
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Serbian
Slovak
Slovenian
Somali
Spanish
Swahili
Swedish
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Vietnamese
Welsh
Yiddish
Yoruba
Zulu
Medicines for Malaria Venture
Developing antimalarials to save lives
Main navigation
Our work
Go back
Our work
MMV's pipeline of antimalarial drugs
Global health and societal change
Go back
Global health and societal change
Sustainable Development Goals
Gender equity
Antimicrobial resistance
Antimalarial drugs for children
African manufacturing
Research and development
Go back
Research and development
Target Product & Candidate Profiles
Frontrunner templates
Access to medicines
Partnering & opportunities
Go back
Partnering & opportunities
Partner network
Business model
Intellectual property rights
Opportunities
Go back
Opportunities
Careers
Requests for information or proposals
Drug discovery call for proposals
Newsroom
Malaria
Go back
Malaria
Definitions and symptoms
Malaria facts and statistics
Lifecycle of malaria parasite
5 species of Plasmodium parasites
History of antimalarial drugs
Malaria guidelines
About us
Go back
About us
About us
Go back
About us
FAQs
Diversity, Equity & Inclusion
Policies
Funding & expenditure
Donors
People & governance
Go back
People & governance
Staff bios
Board of Directors
North America Inc. Board
Access and Product Management Advisory Committee
Expert Scientific Advisory Committee
Global Safety Board
MMVOpen
Go back
MMVOpen
Open compound collections
Go back
Open compound collections
Global health priority box
Pandemic Response Box
Open dose and PK prediction tool
Open source drug discovery programme
MMVOpen team
What are you looking for?
Home
Newsroom
News and Resources Search
How Reagan beat severe malaria
How Reagan beat severe malaria
How Reagan beat severe malaria
25 April 2017
